Google Übersetzer
Dogwood Therapeutics, Inc.
About
Dogwood Therapeutics, Inc. (NASDAQ:DWTX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
Apr 15 2026
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
Mar 18 2026
Dogwood Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 10 2026
CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development
Feb 2 2026
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
Recent Videos
Cómo invertir en Dogwood Therapeutics Inc (DWTX) paso a paso
Mar 27, 2026
Dogwood Therapeutics - $DWTX - Ep:049 - Nano Cap Podcast
Jan 19, 2026
Crashing EUDA, HCTI, AMCI, DWTX, ANEB & NISN Stocks
Dec 22, 2025
My Insight on Dogwood Therapeutics' Capital Raiser 8-K
Dec 01, 2025
Financials
Revenue
$0
Market Cap
$67.26 M
EPS
-7.13